Article Figures & Data
Figures
- Figure 1. Risk checker information flow for men who have one or more of the three main risk factors for prostate cancer. PSA = prostate-specific antigen.
- Figure 2. Monthly proportion of men who answered if the risk checker helped them decide whether to have a PSA blood test or not, January 2022–May 2023. PSA = prostate-specific antigen.
Tables
Characteristics Version 2 Version 3 April 2021–December 2021 January 2022–May 2023 n % n % Total population 118 332 100.0 1 080 029 100.0 Men with prostate cancer risk factors 94 814 80.1 859 842 79.6 Men without prostate cancer risk factors 23 518 19.9 220 187 20.4 Age, years <45 15 423 13.0 135 715 12.6 45–49 10 343 8.7 107 293 9.9 50–54 16 545 14.0 178 292 16.5 55–59 17 488 14.8 186 790 17.3 60–64 19 533 16.5 165 081 15.3 65–69 17 115 14.5 132 276 12.2 ≥70 21 885 18.5 174 583 16.2 Ethnicity Black or Mixed Black 4967 4.2 49 564 4.6 Not Black or Mixed Black 113 365 95.8 1 030 466 95.4 Family history of prostate cancer Yes 16 704 14.1 146 860 13.6 No 101 628 85.9 933 170 86.4
Supplementary Data
- NN_10.3399BJGPO.2024.0040_supp.pdf -
Supplementary material is not copyedited or typeset, and is published as supplied by the author(s). The author(s) retain(s) responsibility for its accuracy.
In this issue
Evaluating whether Prostate Cancer UK’s risk checker is a help or hindrance to prostate-specific antigen testing policy: a mixed-methods study
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals
